Key result
A higher percentage of patients undergoing dialysis more frequently (≥ 3 times/week) was negatively associated with high facility-level hyperkalemia prevalence in Chinese hemodialysis centers.
Why the study?
To examine the prevalence of hyperkalemia, associated practice patterns, and mortality in Chinese patients undergoing hemodialysis.
Observational (n=50,983)
Yes
Hyperkalemia is highly prevalent among Chinese hemodialysis patients, and facilities with higher hyperkalemia prevalence experience significantly higher all-cause and cardiovascular mortality rates.
Answers are grounded in this paper and cite their sources.
Documents HK burden in Chinese HD; leaves open optimal facility-level interventions pending prospective trials.
Visualize-HD study aimed to examine prevalence of hyperkalemia (HK), associated practice patterns, and mortality in Chinese patients undergoing hemodialysis (HD). The study included patients aged ≥ 18 years and undergoing chronic HD for ≥ 3 months. Primary outcome was to examine the association between suspected risk factors and HK prevalence at the HD facility level. Secondary outcomes were to determine the HK prevalence, management pattern of serum potassium (sK), and risk factors associated with crude mortality. Overall, 50,983 patients undergoing HD from 231 HD centers were enrolled. HK prevalence (sK > 5.0 mmol/L) in patients undergoing HD was 40.84%. Proportion of patients sK > 5.5, > 6.0, > 6.5 mmol/L was 20.42%, 8.7%, and 3.21%, respectively. Three-year cumulative mortality of patients undergoing HD was 21.3%. Notably, 36.7% of deceased patients had HK as indicated by their final sK + test results. Facilities in high HK prevalence group had a higher all-cause and cardiovascular mortalities compared with low HK prevalence group (20.7% vs. 21.9% and 11.5% vs. 13.5%; P < 0.05). A higher prevalence of hyperphosphatemia [hazard ratio (HR) 1.04 (95% confidence interval (CI): 1.01–1.07)] and more usage of potassium-binding drugs [HR 1.04 (95% CI: 1.00-1.07)] were positively associated with higher HK prevalence for facilities, whereas hypoalbuminemia prevalence and more elderly patients were reversely associated with higher HK prevalence for facilities. HK is prevalent in Chinese HD centers and is associated with risk factors. Chinese HD centers with a higher HK prevalence had higher mortality rates. Although, long-term sK control is important for improving survival in patients undergoing MHD, potassium-binding drugs are underused. Clinical trial registration number : NCT05020717
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) conducted an observational in Hyperkalemia in hemodialysis patients (n=50,983). Dialysis frequency ≥ 3 times/week vs. Lower dialysis frequency was evaluated on High facility-level hyperkalemia prevalence (> 5.0 mmol/L) (OR 0.986, 95% CI 0.976-0.996, p=0.007). A higher percentage of patients undergoing dialysis more frequently (≥ 3 times/week) was negatively associated with high facility-level hyperkalemia prevalence in Chinese hemodialysis centers.
Synapse has enriched 10 related papers. Consider them for comparative context: